APPLIED MOLECULAR TRANS INC's ticker is AMTI and the CUSIP is 03824M109. A total of 28 filers reported holding APPLIED MOLECULAR TRANS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $567,024 | -39.1% | 3,611,615 | 0.0% | 70.62% | -12.0% |
| Q2 2023 | $931,797 | -19.4% | 3,611,615 | 0.0% | 80.24% | -9.8% |
| Q1 2023 | $1,155,717 | -23.8% | 3,611,615 | 0.0% | 88.90% | +0.6% |
| Q4 2022 | $1,516,878 | -56.7% | 3,611,615 | 0.0% | 88.38% | -0.6% |
| Q3 2022 | $3,503,000 | -66.7% | 3,611,615 | 0.0% | 88.93% | +4.7% |
| Q2 2022 | $10,509,000 | -61.3% | 3,611,615 | 0.0% | 84.90% | +4787.8% |
| Q1 2022 | $27,159,000 | -46.1% | 3,611,615 | 0.0% | 1.74% | -34.9% |
| Q4 2021 | $50,409,000 | -46.0% | 3,611,615 | 0.0% | 2.67% | -91.6% |
| Q3 2021 | $93,432,000 | -43.4% | 3,611,615 | 0.0% | 31.76% | -43.7% |
| Q2 2021 | $165,195,000 | +3.9% | 3,611,615 | 0.0% | 56.39% | +573.0% |
| Q1 2021 | $158,947,000 | +43.0% | 3,611,615 | 0.0% | 8.38% | -70.5% |
| Q4 2020 | $111,129,000 | – | 3,611,615 | – | 28.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund V Management, LLC | 3,611,615 | $567,024 | 70.62% |
| Founders Fund VI Management, LLC | 826,607 | $129,777 | 0.98% |
| EPIQ Capital Group, LLC | 8,689,075 | $1,364,185 | 0.71% |
| GEODE CAPITAL MANAGEMENT, LLC | 139,808 | $21,949 | 0.00% |
| OSAIC HOLDINGS, INC. | 500 | $78 | 0.00% |
| STATE STREET CORP | 55,055 | $8,644 | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 650 | $0 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 49,958 | $7,843 | 0.00% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 66,207 | $10,395 | 0.00% |
| Qube Research & Technologies Ltd | 2,104 | $330 | 0.00% |